Cannabis Law Report

NOVEMBER 12, 2021

” The patent provides protection through 2040 and describes use of the Company’s investigational drug ANEB-001 to treat acute cannabinoid overdose. We recently announced a key milestone with the issuance of a method of use patent for ANEB-001, providing protection through 2040. Condensed Balance Sheet Data. . .

Pharmaceutical 52

Pharmaceutical Clinical Trials Business Research and Development 52

Cannabis Law Report

OCTOBER 26, 2021

Studies estimate that the number of people suffering from rheumatoid arthritis may rise to over 78 million by 2040. 1 Data published by Research and Markets, March 2018. The rising prevalence of rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease are driving demand for TNF inhibitors like MYMD-1. 646) 421-9523.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

JULY 21, 2022

You might not be so excited to learn there are 296 pages of draft legislation to be read which implies to us that the amendment conversation could still be happening when Kyle Jenner is voted president in 2040. Hopefully i’ll be dead by then. Booker, Schumer, Wyden Introduce Cannabis Administration and Opportunity Act. JULY 21, 2022.

Safety 52

Safety Legislation Clinical Trials Banking 52